 | • レポートコード：MRC2-11QY13539 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は5 'ヌクレオチダーゼのグローバル市場について調査・分析したレポートです。種類別（単回投与、併用療法）市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別5 'ヌクレオチダーゼの競争状況、市場シェア ・世界の5 'ヌクレオチダーゼ市場：種類別市場規模 2015年-2020年（単回投与、併用療法） ・世界の5 'ヌクレオチダーゼ市場：種類別市場規模予測 2021年-2026年（単回投与、併用療法） ・世界の5 'ヌクレオチダーゼ市場：用途別市場規模 2015年-2020年（病院、外来手術センター、その他） ・世界の5 'ヌクレオチダーゼ市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、その他） ・北米の5 'ヌクレオチダーゼ市場分析：米国、カナダ ・ヨーロッパの5 'ヌクレオチダーゼ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの5 'ヌクレオチダーゼ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の5 'ヌクレオチダーゼ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの5 'ヌクレオチダーゼ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb、Corvus Pharmaceuticals、Innate Pharma、MedImmune、Surface Oncology、Vitae Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
5′ Nucleotidase (Ecto 5′ Nucleotidase or CD73 or NT5E or EC 3.1.3.5) – 5′-Nucleotidase (5NT) is an intrinsic membrane glycoprotein that is present as an enzyme in a wide variety of mammalian cells. It catalyzes the phosphorylytic cleavage of 5’nucleotides.
Colorectal Cancer, Fallopian Tube Cancer, Gastric Cancer, Metastatic Colorectal Cancer, Others are dominant players in the global 5 Nucleotidase market.
Market Analysis and Insights: Global 5’Nucleotidase Market
The global 5’Nucleotidase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global 5’Nucleotidase Scope and Market Size
5’Nucleotidase market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global 5’Nucleotidase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol-Myers Squibb
Corvus Pharmaceuticals
Innate Pharma
MedImmune
Surface Oncology
Vitae Pharmaceuticals
…
Market segment by Type, the product can be split into
Single Dose
Combination Therapy
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by 5’Nucleotidase Revenue
1.4 Market by Type
1.4.1 Global 5’Nucleotidase Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Single Dose
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global 5’Nucleotidase Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global 5’Nucleotidase Market Perspective (2015-2026)
2.2 Global 5’Nucleotidase Growth Trends by Regions
2.2.1 5’Nucleotidase Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 5’Nucleotidase Historic Market Share by Regions (2015-2020)
2.2.3 5’Nucleotidase Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 5’Nucleotidase Market Growth Strategy
2.3.6 Primary Interviews with Key 5’Nucleotidase Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top 5’Nucleotidase Players by Market Size
3.1.1 Global Top 5’Nucleotidase Players by Revenue (2015-2020)
3.1.2 Global 5’Nucleotidase Revenue Market Share by Players (2015-2020)
3.1.3 Global 5’Nucleotidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global 5’Nucleotidase Market Concentration Ratio
3.2.1 Global 5’Nucleotidase Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by 5’Nucleotidase Revenue in 2019
3.3 5’Nucleotidase Key Players Head office and Area Served
3.4 Key Players 5’Nucleotidase Product Solution and Service
3.5 Date of Enter into 5’Nucleotidase Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global 5’Nucleotidase Historic Market Size by Type (2015-2020)
4.2 Global 5’Nucleotidase Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global 5’Nucleotidase Market Size by Application (2015-2020)
5.2 Global 5’Nucleotidase Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America 5’Nucleotidase Market Size (2015-2020)
6.2 5’Nucleotidase Key Players in North America (2019-2020)
6.3 North America 5’Nucleotidase Market Size by Type (2015-2020)
6.4 North America 5’Nucleotidase Market Size by Application (2015-2020)
7 Europe
7.1 Europe 5’Nucleotidase Market Size (2015-2020)
7.2 5’Nucleotidase Key Players in Europe (2019-2020)
7.3 Europe 5’Nucleotidase Market Size by Type (2015-2020)
7.4 Europe 5’Nucleotidase Market Size by Application (2015-2020)
8 China
8.1 China 5’Nucleotidase Market Size (2015-2020)
8.2 5’Nucleotidase Key Players in China (2019-2020)
8.3 China 5’Nucleotidase Market Size by Type (2015-2020)
8.4 China 5’Nucleotidase Market Size by Application (2015-2020)
9 Japan
9.1 Japan 5’Nucleotidase Market Size (2015-2020)
9.2 5’Nucleotidase Key Players in Japan (2019-2020)
9.3 Japan 5’Nucleotidase Market Size by Type (2015-2020)
9.4 Japan 5’Nucleotidase Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia 5’Nucleotidase Market Size (2015-2020)
10.2 5’Nucleotidase Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia 5’Nucleotidase Market Size by Type (2015-2020)
10.4 Southeast Asia 5’Nucleotidase Market Size by Application (2015-2020)
11 India
11.1 India 5’Nucleotidase Market Size (2015-2020)
11.2 5’Nucleotidase Key Players in India (2019-2020)
11.3 India 5’Nucleotidase Market Size by Type (2015-2020)
11.4 India 5’Nucleotidase Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America 5’Nucleotidase Market Size (2015-2020)
12.2 5’Nucleotidase Key Players in Central & South America (2019-2020)
12.3 Central & South America 5’Nucleotidase Market Size by Type (2015-2020)
12.4 Central & South America 5’Nucleotidase Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview
13.1.3 Bristol-Myers Squibb 5’Nucleotidase Introduction
13.1.4 Bristol-Myers Squibb Revenue in 5’Nucleotidase Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Corvus Pharmaceuticals
13.2.1 Corvus Pharmaceuticals Company Details
13.2.2 Corvus Pharmaceuticals Business Overview
13.2.3 Corvus Pharmaceuticals 5’Nucleotidase Introduction
13.2.4 Corvus Pharmaceuticals Revenue in 5’Nucleotidase Business (2015-2020)
13.2.5 Corvus Pharmaceuticals Recent Development
13.3 Innate Pharma
13.3.1 Innate Pharma Company Details
13.3.2 Innate Pharma Business Overview
13.3.3 Innate Pharma 5’Nucleotidase Introduction
13.3.4 Innate Pharma Revenue in 5’Nucleotidase Business (2015-2020)
13.3.5 Innate Pharma Recent Development
13.4 MedImmune
13.4.1 MedImmune Company Details
13.4.2 MedImmune Business Overview
13.4.3 MedImmune 5’Nucleotidase Introduction
13.4.4 MedImmune Revenue in 5’Nucleotidase Business (2015-2020)
13.4.5 MedImmune Recent Development
13.5 Surface Oncology
13.5.1 Surface Oncology Company Details
13.5.2 Surface Oncology Business Overview
13.5.3 Surface Oncology 5’Nucleotidase Introduction
13.5.4 Surface Oncology Revenue in 5’Nucleotidase Business (2015-2020)
13.5.5 Surface Oncology Recent Development
13.6 Vitae Pharmaceuticals
13.6.1 Vitae Pharmaceuticals Company Details
13.6.2 Vitae Pharmaceuticals Business Overview
13.6.3 Vitae Pharmaceuticals 5’Nucleotidase Introduction
13.6.4 Vitae Pharmaceuticals Revenue in 5’Nucleotidase Business (2015-2020)
13.6.5 Vitae Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. 5'Nucleotidase Key Market Segments
Table 2. Key Players Covered: Ranking by 5'Nucleotidase Revenue
Table 3. Ranking of Global Top 5'Nucleotidase Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global 5'Nucleotidase Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Single Dose
Table 6. Key Players of Combination Therapy
Table 7. Global 5'Nucleotidase Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global 5'Nucleotidase Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global 5'Nucleotidase Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global 5'Nucleotidase Market Share by Regions (2015-2020)
Table 11. Global 5'Nucleotidase Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global 5'Nucleotidase Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. 5'Nucleotidase Market Growth Strategy
Table 17. Main Points Interviewed from Key 5'Nucleotidase Players
Table 18. Global 5'Nucleotidase Revenue by Players (2015-2020) (Million US$)
Table 19. Global 5'Nucleotidase Market Share by Players (2015-2020)
Table 20. Global Top 5'Nucleotidase Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 5'Nucleotidase as of 2019)
Table 21. Global 5'Nucleotidase by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players 5'Nucleotidase Product Solution and Service
Table 24. Date of Enter into 5'Nucleotidase Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global 5'Nucleotidase Market Size by Type (2015-2020) (Million US$)
Table 27. Global 5'Nucleotidase Market Size Share by Type (2015-2020)
Table 28. Global 5'Nucleotidase Revenue Market Share by Type (2021-2026)
Table 29. Global 5'Nucleotidase Market Size Share by Application (2015-2020)
Table 30. Global 5'Nucleotidase Market Size by Application (2015-2020) (Million US$)
Table 31. Global 5'Nucleotidase Market Size Share by Application (2021-2026)
Table 32. North America Key Players 5'Nucleotidase Revenue (2019-2020) (Million US$)
Table 33. North America Key Players 5'Nucleotidase Market Share (2019-2020)
Table 34. North America 5'Nucleotidase Market Size by Type (2015-2020) (Million US$)
Table 35. North America 5'Nucleotidase Market Share by Type (2015-2020)
Table 36. North America 5'Nucleotidase Market Size by Application (2015-2020) (Million US$)
Table 37. North America 5'Nucleotidase Market Share by Application (2015-2020)
Table 38. Europe Key Players 5'Nucleotidase Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players 5'Nucleotidase Market Share (2019-2020)
Table 40. Europe 5'Nucleotidase Market Size by Type (2015-2020) (Million US$)
Table 41. Europe 5'Nucleotidase Market Share by Type (2015-2020)
Table 42. Europe 5'Nucleotidase Market Size by Application (2015-2020) (Million US$)
Table 43. Europe 5'Nucleotidase Market Share by Application (2015-2020)
Table 44. China Key Players 5'Nucleotidase Revenue (2019-2020) (Million US$)
Table 45. China Key Players 5'Nucleotidase Market Share (2019-2020)
Table 46. China 5'Nucleotidase Market Size by Type (2015-2020) (Million US$)
Table 47. China 5'Nucleotidase Market Share by Type (2015-2020)
Table 48. China 5'Nucleotidase Market Size by Application (2015-2020) (Million US$)
Table 49. China 5'Nucleotidase Market Share by Application (2015-2020)
Table 50. Japan Key Players 5'Nucleotidase Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players 5'Nucleotidase Market Share (2019-2020)
Table 52. Japan 5'Nucleotidase Market Size by Type (2015-2020) (Million US$)
Table 53. Japan 5'Nucleotidase Market Share by Type (2015-2020)
Table 54. Japan 5'Nucleotidase Market Size by Application (2015-2020) (Million US$)
Table 55. Japan 5'Nucleotidase Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players 5'Nucleotidase Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players 5'Nucleotidase Market Share (2019-2020)
Table 58. Southeast Asia 5'Nucleotidase Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia 5'Nucleotidase Market Share by Type (2015-2020)
Table 60. Southeast Asia 5'Nucleotidase Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia 5'Nucleotidase Market Share by Application (2015-2020)
Table 62. India Key Players 5'Nucleotidase Revenue (2019-2020) (Million US$)
Table 63. India Key Players 5'Nucleotidase Market Share (2019-2020)
Table 64. India 5'Nucleotidase Market Size by Type (2015-2020) (Million US$)
Table 65. India 5'Nucleotidase Market Share by Type (2015-2020)
Table 66. India 5'Nucleotidase Market Size by Application (2015-2020) (Million US$)
Table 67. India 5'Nucleotidase Market Share by Application (2015-2020)
Table 68. Central & South America Key Players 5'Nucleotidase Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players 5'Nucleotidase Market Share (2019-2020)
Table 70. Central & South America 5'Nucleotidase Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America 5'Nucleotidase Market Share by Type (2015-2020)
Table 72. Central & South America 5'Nucleotidase Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America 5'Nucleotidase Market Share by Application (2015-2020)
Table 74. Bristol-Myers Squibb Company Details
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Product
Table 77. Bristol-Myers Squibb Revenue in 5'Nucleotidase Business (2015-2020) (Million US$)
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Corvus Pharmaceuticals Company Details
Table 80. Corvus Pharmaceuticals Business Overview
Table 81. Corvus Pharmaceuticals Product
Table 82. Corvus Pharmaceuticals Revenue in 5'Nucleotidase Business (2015-2020) (Million US$)
Table 83. Corvus Pharmaceuticals Recent Development
Table 84. Innate Pharma Company Details
Table 85. Innate Pharma Business Overview
Table 86. Innate Pharma Product
Table 87. Innate Pharma Revenue in 5'Nucleotidase Business (2015-2020) (Million US$)
Table 88. Innate Pharma Recent Development
Table 89. MedImmune Company Details
Table 90. MedImmune Business Overview
Table 91. MedImmune Product
Table 92. MedImmune Revenue in 5'Nucleotidase Business (2015-2020) (Million US$)
Table 93. MedImmune Recent Development
Table 94. Surface Oncology Company Details
Table 95. Surface Oncology Business Overview
Table 96. Surface Oncology Product
Table 97. Surface Oncology Revenue in 5'Nucleotidase Business (2015-2020) (Million US$)
Table 98. Surface Oncology Recent Development
Table 99. Vitae Pharmaceuticals Company Details
Table 100. Vitae Pharmaceuticals Business Overview
Table 101. Vitae Pharmaceuticals Product
Table 102. Vitae Pharmaceuticals Revenue in 5'Nucleotidase Business (2015-2020) (Million US$)
Table 103. Vitae Pharmaceuticals Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global 5'Nucleotidase Market Share by Type: 2020 VS 2026
Figure 2. Single Dose Features
Figure 3. Combination Therapy Features
Figure 4. Global 5'Nucleotidase Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Others Case Studies
Figure 8. 5'Nucleotidase Report Years Considered
Figure 9. Global 5'Nucleotidase Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global 5'Nucleotidase Market Share by Regions: 2020 VS 2026
Figure 11. Global 5'Nucleotidase Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global 5'Nucleotidase Market Share by Players in 2019
Figure 14. Global Top 5'Nucleotidase Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in 5'Nucleotidase as of 2019
Figure 15. The Top 10 and 5 Players Market Share by 5'Nucleotidase Revenue in 2019
Figure 16. North America 5'Nucleotidase Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe 5'Nucleotidase Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China 5'Nucleotidase Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan 5'Nucleotidase Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia 5'Nucleotidase Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India 5'Nucleotidase Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America 5'Nucleotidase Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
併用抗体療法の世界市場（～2026年） Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination ant…- 美学併用療法の世界市場（～2026年） Combination treatment in aesthetic market consists of various treatment approaches such as neuromodulators, derma fillers, topical therapies, intense pulsed light photo rejuvenation, laser therapies, radiofrequency-based therapies and ultra-radiofrequency-based therapies. The market is expected to w…
- 外来手術センターの世界市場（～2026年） Market Analysis and Insights: Global Ambulatory Surgical Centres Market The global Ambulatory Surgical Centres market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ambulatory Surgical Centres Scope and Market Size Ambulator…
- 単回投与洗剤の世界市場（～2026年） Market Analysis and Insights: Global Single Dose Detergent Market The global Single Dose Detergent market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Single Dose Detergent Scope and Market Size Single Dose Detergent marke…
- 瘢痕併用療法の世界市場（～2026年） Scar treatment is a technique that is utilized to limit the scars marks so that it seem more consistent with the skin tone and surface surrounding. Scars are marks that stay after a wound recovers and unavoidable aftereffects of damage or surgery. Scars are of different types, which includes keloid …